Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Economic assessment of platelet glycoprotein iib/iiia inhibition for prevention of ischemic complications of high-risk coronary angioplasty

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Mark, D. B.
  • Talley, J. D.
  • Topol, Eric
  • Bowman, L.
  • Lam, L. C.
  • Anderson, K. M.
  • Jollis, J. G.
  • Cleman, M. W.
  • Lee, K. L.
  • Aversano, T.
  • Untereker, W. J.
  • DavidsonRay, L.
  • Califf, R. M.

publication date

  • August 1996

journal

  • Circulation  Journal

subject areas

  • Aged
  • Angioplasty
  • Antibodies, Monoclonal
  • Anticoagulants
  • Aspirin
  • Blood Transfusion
  • Costs and Cost Analysis
  • Double-Blind Method
  • Female
  • Heparin
  • Humans
  • Immunoglobulin Fab Fragments
  • Infusions, Intravenous
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Myocardial Ischemia
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recurrence
  • Stents
  • Treatment Outcome
  • United States
scroll to property group menus

Research

keywords

  • angioplasty
  • cost-benefit analysis
  • glycoproteins
  • trials
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 8772681
scroll to property group menus

Additional Document Info

start page

  • 629

end page

  • 635

volume

  • 94

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support